Hepatoprotecive Effects of Puerariae Flos Extract on Experimental Non-alcoholic Fatty Liver Disease Models |
Hwang, Hyeong-Chil
(Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University)
Kong, Ryong (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University) Kang, Ok-Hwa (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University) Kwo, Dong-Yeul (Department of Oriental Pharmacy, College of Pharmacy, Wonkwang Oriental Medicines Research Institute, Wonkwang University) |
1 | Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74-80. DOI |
2 | Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Path. 1989;20:594-598. DOI |
3 | Bacon BR, Faragvash MJ, Janny CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an espanded clinical entity. Gastroenterology. 1994;107:1103-1109. DOI |
4 | Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in sterptozotocin-induced diabetic rats. J Nature Products. 2003;66:788-792. DOI |
5 | Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharmacal Res. 2007;30:1309-1317. DOI |
6 | Gervois P, Torra IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med. 2000;38:3-11. |
7 | Foretz M, Guichard C, Ferre P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci. 1999;96:12737-12742. DOI |
8 | Morrison CD, Huypens P, Stewart LK, Gettys TW. Implications of cross talk between leptin and insulin signaling during the development of dietinduced obesity. Biochim Biophys Acta. 2009;1792: 409-416. DOI |
9 | Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV and O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact. 2007;165(2):106-116. DOI |
10 | Ko JS. Dermatology. Soomoonsa Press. 2000:73. |
11 | Pavel S, Muskiet FA. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma, a preliminary report. Cancer Detect Prev. 1983;6:311-316. |
12 | Prota, G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980;75:122-127. DOI |
13 | Masashi N, Yasuteru K,Tooru S. Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis. 2012;2013:237870. doi: 10.1155/2013/237870. DOI |
14 | Parvez S, M Kang, HS Chung, C Cho, MC Hong, MK Shin, H Bae. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res. 2006;20:921-934. DOI |
15 | Mayer A. M. Polyphenol oxidases in plants recent progress. Phytochemistry. 1987;26:11-20. |
16 | Cabanes JS, Chazarra S, Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol. 1994;46:982-985. DOI |
17 | Kim CM, Sin MK, Lee KS, Ahn DK. Encyclopedia of oriental herbal medicine. Seoul:Jeongdam. 2004;2307. |
18 | Andrew J Lickteig, Craig D Fisher, Lisa M Augustine, Nathan J. Cherrington. Genes of the Antioxidant Response Undergo Upregulation in a Rodent Model of Nonalcoholic Steatohepatitis. J Biochem Molecular Toxicology. 2007;219:216-220. |
19 | Mu Y-ping, Ogawa T, Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-cholinedeficient diet. Laboratory Investigation. J Technical Methods and Pathology. 2010;90:245-256. |
20 | Heo J. Hwang sil donguibogam. Seoul: Geumjinpublishing. 1993;927. |
21 | Kim TJ, Resources plants in Korea. Seoul:Seoul National University Publishing Council, 1986;232. |
22 | Kubo M, Fujita K. A new irisolidone-7-Oglucoside and tectoridin from Pueraria species. Phytochemistry. 1973;12:25-47. DOI |
23 | Kubo M, Sasaki M, Namba K, Naruto S, Nishimura H. Isolation of a new isoflavone from chinese Pueraria Flower. Chem Pharm Bull. 1975;23:2449-2451. DOI |
24 | Kurihara T, Kikuchi. Studies on the constituents of Flower (1): On the constituents of Flower of Pueraria thunbergiana Benth (2). Isolation of a new isoflavone glycoside. Yakugaku Zasshi. 1975;95: 1283-1285. DOI |
25 | Park HJ, Park JH, Moon JO, Lee KT, Jung WT, Oh SR, Lee HK. Isoflavone glycosides from the Flower of Pueraria thunbergiana. Phytochemistry. 1999;51:147-151. DOI |
26 | Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC, Cheng JT. Antihyperglycemic effect of puerarin in sterptozotocin-induced diabetic rats. J Nature Products. 2003;66:788-792. DOI |
27 | Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231. DOI |
28 | Hwang YP, Choi CY, Chung YC, Jeon SS, Jeong HG. Protective effects of puerarin on carbon tetrachloride-induced hepatotoxicity. Arch Pharmacal Res. 2007;30:1309-1317. DOI |
29 | Falchuk FR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology. 1980;78:535-541. |
30 | Bacon BR. Genetic, metabolic, and infiltrative diseases affecting the liver. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill. 2008;1980-1983 |
31 | Yun JW, Cho YK. Clinical impact of non-alcoholic fatty liver disease on other medical diseases. Korean J Intern Med. 2009;76(1):25-29. |
32 | Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis. 2002;6(2):399-420. DOI |
33 | Leevy CM. Fatty liver. A study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine. 1962;41:249-276. DOI |
34 | Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12: 1106-1110. DOI |
35 | Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. 1986;220:83-88. |
36 | Kim MJ, Park CH, Kim DH, Park MH, Park KC, Hyun MK, Lee AK, Moon HR, Chung HY. Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats. Molecules. 2018;23(8). doi: 10.3390/molecules23082057. DOI |